Myelogram-Related Arachnoiditis Amendments of 1995
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jan 9, 1995)
Myelogram-Related Arachnoiditis Amendments of 1995 - Amends the Federal Food, Drug, and Cosmetic Act to prohibit a myelogram involving the use of Pantopaque, Amipaque, Omipacque, or Isovue.
Amends the Public Health Service Act to require a study and research with respect to individuals who have undergone a myelogram and who have subsequently developed arachnoiditis.
What just happenedFeb 6, 1995
Referred to the Subcommittee on Health and Environment.
Who’s behind it
- Introduced in HouseJan 9, 1995
- Feb 6, 1995CommitteeH11000
Referred to the Subcommittee on Health and Environment.
Health and Environment Subcommittee - Jan 11, 1995IntroReferralB00100
Sponsor introductory remarks on measure. (CR E77)
- Jan 9, 1995IntroReferralH11100
Referred to the House Committee on Commerce.
Energy and Commerce Committee - Jan 9, 1995IntroReferralIntro-H
Introduced in House
- Jan 9, 1995IntroReferral1000
Introduced in House